FRESENIUS SE &/S (OTCMKTS:FSNUY) announced an annual dividend on Monday, April 8th, Zacks reports. Investors of record on Tuesday, May 21st will be paid a dividend of 0.15 per share on Thursday, May 30th. This represents a yield of 1.03%. The ex-dividend date of this dividend is Monday, May 20th.

OTCMKTS:FSNUY opened at $13.71 on Wednesday. The company has a market cap of $30.70 billion, a PE ratio of 12.55, a P/E/G ratio of 2.08 and a beta of 1.25. FRESENIUS SE &/S has a 52 week low of $11.00 and a 52 week high of $20.64.

FRESENIUS SE &/S (OTCMKTS:FSNUY) last posted its earnings results on Thursday, May 2nd. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.02. The company had revenue of $9.65 billion during the quarter. FRESENIUS SE &/S had a return on equity of 12.53% and a net margin of 5.91%. On average, sell-side analysts predict that FRESENIUS SE &/S will post 0.95 EPS for the current fiscal year.

Several equities analysts have recently commented on FSNUY shares. Goldman Sachs Group reaffirmed a “buy” rating on shares of FRESENIUS SE &/S in a report on Friday, March 22nd. Zacks Investment Research raised FRESENIUS SE &/S from a “sell” rating to a “buy” rating and set a $15.00 target price for the company in a report on Monday, February 18th. Barclays lowered FRESENIUS SE &/S from an “overweight” rating to an “equal weight” rating in a report on Tuesday, January 15th. Finally, Jefferies Financial Group reissued a “hold” rating on shares of FRESENIUS SE &/S in a report on Thursday, March 7th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $15.00.

TRADEMARK VIOLATION WARNING: “FRESENIUS SE &/S (FSNUY) Announces $0.15 Annual Dividend” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at

FRESENIUS SE &/S Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Recommended Story: What is a put option?

Receive News & Ratings for FRESENIUS SE &/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FRESENIUS SE &/S and related companies with's FREE daily email newsletter.